Table 5.

Comparison of OS and ORR for the JULIET ITT vs CORAL follow-up ITT populations

MethodNMedian (95% CI) OS, moHR (JULIET vs CORAL Follow up)
JULIETCORAL follow-upJULIETCORAL follow-upEstimate (95% CI)P
OS       
 Unadjusted analyses 166 205 8.25 (5.82, 11.70) 5.13 (3.88, 6.21) 0.65 (0.51, 0.83) <.001* 
 Adjusted analyses 
  FSW 163 205 8.25 (5.82, 12.42) 4.86 (3.52, 6.08) 0.60 (0.44, 0.77) <.001* 
  SMRW 163 205 8.25 (5.82, 12.42) 4.04 (3.25, 5.75) 0.57 (0.44, 0.73) <.001* 
MethodNMedian (95% CI) OS, moHR (JULIET vs CORAL Follow up)
JULIETCORAL follow-upJULIETCORAL follow-upEstimate (95% CI)P
OS       
 Unadjusted analyses 166 205 8.25 (5.82, 11.70) 5.13 (3.88, 6.21) 0.65 (0.51, 0.83) <.001* 
 Adjusted analyses 
  FSW 163 205 8.25 (5.82, 12.42) 4.86 (3.52, 6.08) 0.60 (0.44, 0.77) <.001* 
  SMRW 163 205 8.25 (5.82, 12.42) 4.04 (3.25, 5.75) 0.57 (0.44, 0.73) <.001* 
MethodNORR, (%)Response rate difference (JULIET Main Cohort vs CORAL Follow-up)
JULIET main cohortCORAL follow-upJULIET main cohortCORAL follow-upEstimate (95% CI)P
ORR       
 Unadjusted analyses 146 205 37% 30% 0.07 (–0.03, 0.17) .191 
 Adjusted analyses 
  FSW 143 205 38% 29% 0.09 (–0.01, 0.20) .097 
  SMRW 143 205 38% 27% 0.11 (0.00, 0.22) .043* 
MethodNORR, (%)Response rate difference (JULIET Main Cohort vs CORAL Follow-up)
JULIET main cohortCORAL follow-upJULIET main cohortCORAL follow-upEstimate (95% CI)P
ORR       
 Unadjusted analyses 146 205 37% 30% 0.07 (–0.03, 0.17) .191 
 Adjusted analyses 
  FSW 143 205 38% 29% 0.09 (–0.01, 0.20) .097 
  SMRW 143 205 38% 27% 0.11 (0.00, 0.22) .043* 
*

P < .05.

Age at initial diagnosis, status of disease, time to 2L start after diagnosis, prior HCT, and number of relapses were included in the adjusted analysis.

or Create an Account

Close Modal
Close Modal